obacunone has been researched along with Hyperglycemia, Postprandial in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Y; Peng, S; Wang, H; Wang, T; Zhou, J | 1 |
| Horiba, T; Katsukawa, M; Mita, M; Sato, R | 1 |
| Hashidume, T; Inoue, J; Ono, E; Sato, R; Shimizu, M | 1 |
3 other study(ies) available for obacunone and Hyperglycemia, Postprandial
| Article | Year |
|---|---|
Obacunone attenuates high glucose-induced oxidative damage in NRK-52E cells by inhibiting the activity of GSK-3β.
Topics: Animals; Antioxidants; Benzoxepins; Cell Line; Diabetic Nephropathies; Drugs, Chinese Herbal; Glucose; Glycogen Synthase Kinase 3 beta; Hyperglycemia; Kidney; Limonins; Oxidative Stress; Rats | 2019 |
Dietary obacunone supplementation stimulates muscle hypertrophy, and suppresses hyperglycemia and obesity through the TGR5 and PPARγ pathway.
Topics: Animals; Benzoxepins; Dietary Supplements; HEK293 Cells; Humans; Hyperglycemia; Hypertrophy; Limonins; Metabolic Syndrome; Mice; Muscle, Skeletal; Obesity; PPAR gamma; Receptors, G-Protein-Coupled | 2015 |
Anti-obesity and anti-hyperglycemic effects of the dietary citrus limonoid nomilin in mice fed a high-fat diet.
Topics: Animals; Anti-Obesity Agents; Benzoxepins; Blood Glucose; Citrus; Diet; Dietary Fats; Gene Expression; HEK293 Cells; Humans; Hyperglycemia; Hypolipidemic Agents; Insulin; Iodide Peroxidase; Iodothyronine Deiodinase Type II; Ligands; Limonins; Male; Mice; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Receptors, G-Protein-Coupled; Trans-Activators; Transcription Factors | 2011 |